Abstract
The occurrence of autoimmunity is strongly associated with multiple gene variants that predispose individuals to disease. The identification of the gene polymorphisms that modulate disease susceptibility is key to our understanding of disease etiology and pathogenesis. While genetic studies in humans have uncovered several associations and have provided possible candidate genes for further study, the use of animal models is indispensable for detailed functional studies. In order to facilitate the genetic manipulation of experimental models of autoimmunity, we employ lentiviral transgenesis in combination with RNA interference (RNAi). This approach bypasses the need for targeted mutagenesis of embryonic stem cells and/or backcrossing of genetically modified animals onto the relevant genetic background. Lentiviral RNAi offers several advantages compared to conventional transgenesis or knockout technology, and these, as well as the technique’s weaknesses, are discussed herein.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Lois C., Hong E.J., Pease S., Brown E.J. and Baltimore D. (2002) Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295: 868–872.
Brummelkamp T.R., Bernards R. and Agami R. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550–553.
Rubinson et al. (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet.33: 401–406.
Tiscornia G., Singer O., Ikawa M. and Verma I.M. (2003) A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl. Acad. Sci. USA 100: 1844–1848.
Ventura A., Meissner A., Dillon C.P., McManus M.T., Sharp P.A., Van Parijs L., Jaenisch R. and Jacks T. (2004) Cre-lox conditional RNA interference from transgenes. Proc. Natl. Acad. Sci. USA 101: 10380–10385.
Szulc J., Wiznerowicz M., Sauvain M.-O., Trono D., and Aebischer P. (2006) A versatile tool for conditional gene expression and knockdown. Nat. Methods 3: 109–116.
Kissler S., Stern P., Takahashi K., Hunter K., Peterson L.B. and Wicker L.S. (2006) In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes. Nat. Genet.38: 479–483.
Stegmeier F., Hu G., Rickles R.J., Hannon G.J., and Elledge S.J. (2005) A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc. Natl. Acad. Sci. USA102: 13212–13217.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Kissler, S. (2009). Studying Autoimmunity by In Vivo RNA Interference. In: Rondinone, C., Reidhaar-Olson, J. (eds) Therapeutic Applications of RNAi. Methods in Molecular Biology™, vol 555. Humana Press. https://doi.org/10.1007/978-1-60327-295-7_8
Download citation
DOI: https://doi.org/10.1007/978-1-60327-295-7_8
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-294-0
Online ISBN: 978-1-60327-295-7
eBook Packages: Springer Protocols